About Us

Meet Us at the Antibody Engineering & Therapeutics (US) 2022

Antibody Engineering & Therapeutics (US) 2022
Antibody Engineering & Therapeutics (US) 2022

Antibody Engineering & Therapeutics (US) 2022

December 4-8, 2022

Marriott Marquis San Diego Marina, 333 West Harbor Drive, San Diego, CA 92101, USA

Booth #418

As the annual meeting of the Antibody Society, the Antibody Engineering & Therapeutics has been recognized as one of the top antibody engineering conferences for accelerating next-generation antibodies to commercial success. The brand-new topic streams in the Antibody Engineering & Therapeutics (US) 2022 will cover the following key areas:

  • Antibody engineering, libraries and selection (including HTS) 
  • Machine learning/artificial intelligence in antibody discovery and engineering 
  • Fc-engineering & other (non IgG1/IgG4) subclasses 
  • Antibody-drug conjugates 
  • Advancing antibody therapeutics in immuno-oncology 
  • Tumor microenvironment (including immunocytokines) 
  • Novel/difficult targets for antibody therapeutics (e.g., MHCp, GPRC, glycans) 
  • How to develop an antibody-based drug: from discovery to IND? 
  • Adaptive immune receptor repertoire data processing, annotation and interpretation 
  • Antibodies in non-cancer (autoimmune, neurological and other diseases) 
  • Functional screening integrated into initial antibody discovery 
  • Antibody-drug conjugates, toxins and other conjugates 
  • Cellular therapies: CART's (T and NK) (non-cell engaging) 
  • Bispecifics/multispecifics/combinations (non-cell engaging) 
  • Antibodies in infectious diseases 
  • T cell (including gamma/delta) and NK cell engagers

Meet us at the Antibody Engineering & Therapeutics (US) 2022! Our specialists are excited to discuss how Creative Biolabs can help develop and optimize your antibody therapeutics. Feel free to leave your contact information below and tell us your project needs!

See Where We Were in 2022—Archive of Creative Biolabs' Events